# Sarkana Pharma, Inc. — Form D

Sarkana Pharma, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-17. $1.6M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-02-17
- Form: D
- Accession: 0001845313-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $1.6M
- Investors: 1
- Date of first sale: 2020-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-389612

## Issuer

- Name: Sarkana Pharma, Inc.
- CIK: 0001845313
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1000 N. WEST ST., SUITE 1200, WILMINGTON, DE, 19801
- Phone: 6493324417

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Luc Marengere | Director | Roseville, MN |
| Mark Cipriano | Executive Officer | Wilmington, DE |
| Caroline Fortier | Executive Officer | Wilmington, DE |

## More

- [CIK 1845313 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1845313&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001845313-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.